Biogen Raises Revenue Guidance, Reiterates Earnings Guidance
July 22 2021 - 8:15AM
Dow Jones News
By Matt Grossman
Biogen Inc. Thursday raised its full-year revenue forecast
Thursday, but held constant its earnings outlook.
The Cambridge, Mass.-based drug maker said it now expects
revenue of $10.65 billion to $10.85 billion in 2021. It had
previously forecast revenue of $10.45 to $10.75 billion.
Biogen held steady its adjusted earnings forecast, targeting
earnings of $17.50 to $19 a share.
Analysts surveyed by FactSet had been forecasting adjusted
earnings of $18.50 a share on sales of $10.61 billion.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 22, 2021 08:01 ET (12:01 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2023 to Apr 2024